期刊文献+

82例社区获得性肺炎病原体调查分析 被引量:4

Pathogens analysis of 82 community-acquired pneumonia
下载PDF
导出
摘要 目的调查社区获得性肺炎(CAP)的病原体分布,为本社区CAP的经验性治疗提供依据。方法收集2006年1月~2008年1月CAP患者共82例,分别留取呼吸道分泌物进行细菌培养,应用常规方法分离鉴定细菌,同时检测患者急性期和恢复期肺炎支原体、肺炎衣原体、嗜肺军团菌血清抗体。结果82例CAP患者48例(58.5%)病原学检查阳性。检出肺炎支原体14例;肺炎衣原体5例;嗜肺军团菌3例。分离出流感嗜血杆菌15例;肺炎链球菌10例;卡他莫拉菌5例;肺炎克雷伯杆菌2例;金黄色葡萄球菌2例。14例为混合感染。结论流感嗜血杆菌和肺炎链球菌仍是CAP的主要致病菌。非典型病原体在CAP中占有重要地位,且多为混合感染。 Aim To investigate the pathogens of community-acquired pneumonia(CAP) ,and to provide therapy evidence community-acquired pneumonia for drug resistance of isolated bacteria. Methods A prospective study was performed on 82 adult patients with CAP from January 2006 to January 2008. Sputum samples were collected for culture. Bacteria were isolated and identifiedby by using conventional methods. Antibodies of the paired serum samples to mycoplasma pneumonia, chlamydia pneumonia, and legionella pneumophila were detected. Results The etiology of CAP was identified in 48 patients. The distribution of casual agents was as follows : haemophilus influenzae 15, streptococcus pneumoniae 10, moraxelle eatarrhalis 5, klebsiella pneumoniae 2, staphylococcus aureus 2, mycoplasma pneumonia 14,chlamydia pneumoniae 5, legionella pneumophila 3. In 14 patients more than one causal agent were found. Conclusions Haemophilus influenzae and streptococcus pneumoniae were the most common bacteria for CAP. Adult CAP was caused by atypical pathogens and the rate of mixed infection was high.
作者 韩路兴
出处 《安徽医药》 CAS 2009年第11期1363-1364,共2页 Anhui Medical and Pharmaceutical Journal
关键词 社区获得性肺炎 病原体 community - acquired pneumonia pathogens
  • 相关文献

参考文献8

  • 1社区获得性肺炎诊断和治疗指南(草案)[J].中华结核和呼吸杂志,1999,22(4):199-201. 被引量:1036
  • 2Bartlett JG, Mundy LM. Community -acquired pneumonia[ J ]. New Engl J Med, 1995,333 : 1618 - 24.
  • 3Niederman MS, Mandell LA, Anzueto A, et al. Guidelines for the management of adults with community - acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention [ J]. Am J Respir Crit Care Med ,2001,163:1730 -54.
  • 4刘又宁,陈民钧,赵铁梅,王辉,王睿,刘庆锋,蔡柏蔷,曹彬,孙铁英,胡云建,修清玉,周新,丁星,杨岚,卓建生,唐英春,张扣兴,梁德荣,吕晓菊,李胜歧,刘勇,俞云松,魏泽庆,应可净,赵峰,陈萍,侯晓娜.中国城市成人社区获得性肺炎665例病原学多中心调查[J].中华结核和呼吸杂志,2006,29(1):3-8. 被引量:784
  • 5黄海辉,张婴元,黄绍光,陆权,周新,修清玉,王岱明,吴卫红,汪复.上海地区社区获得性肺炎的病原学调查[J].中国抗感染化疗杂志,2003,3(6):321-324. 被引量:147
  • 6Ruiz - Gonzalez A, Falguera M, Nogues K, et al. Is Streptococcus pneumoniae the leading cause of pneumonia of unknown etiology? A microbiologic study of lung aspirates in consecutive patients with community - acquired pneumonia [ J ]. Am J Med, 1999,106 : 385 - 90.
  • 7孙彩霞,张颖.老年人社区获得性肺炎145例临床分析[J].中国临床保健杂志,2004,7(6):436-437. 被引量:4
  • 8Charles PG,Whitby M. The etiology of community -acquired pneumonia in Australia:why penicillin plus doxycycline or a macrolide is the most appropriate therapy [ J ]. Clin Infect Dis, 2008,46 ( 10 ) : 1513 -21.

二级参考文献22

  • 1Ngeow YF,Suwanjutha S,Chantarojanasriri T,et al.An asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia.Int J Infect Dis,2005,9:144-153.
  • 2Lepow ML,Balassanian N,Emmerich J,et al.Interrelationships of viral,mycoplasmal,and bacterial agents in uncomplicated pneumonia.Am Rev Respir Dis,1968,97:533-545.
  • 3Lim WS,Macfarlane JT,Boswell TC,et al.Study of community acquired pneumonia aetiology(SCAPA) in adults admitted to hospital:implications for management guidelines.Thorax,2001,56:296-301.
  • 4Niederman MS,Mandell LA,Anzueto A,et al.Guidelines for the management of adults with community-acquired pneumonia.Diagnosis,assessment of severity,antimicrobial therapy,and prevention.Am J Respir Crit Care Med,2001,163:1730-1754.
  • 5Heffelfinger JD,Dowell SF,Jorgensen JH,et al.Management of community-acquired pneumonia in the era of pneumococcal resistance:a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group.Arch Intern Med,2000,160:1399-1408.
  • 6[1]Gaydos CA,Quinn TC ,Eiden JJ.Identification of Chlamydia pneumoniae by DNA amplification of the 16SrRNA gene[J]. J Clin Microbiol, 1992, 30:796-800
  • 7[2]Ieven M,Ursi D, van Bever H, et al.Detection of Mycoplasma pneumoniae by two polymerase chain reactions and role of M.pneumoniae in acute respiratory tract infections in pediatric patients[J]. J Infect Dis,1996, 173:1445-1452
  • 8[3]Darelid J,Lofgren S,Malmvall BE,et al.Legionella pneumophila serogroup 1 antibody kinetics in patients with Legionnaires' disease:implications for serological diagnosis[J]. Scand J Infect Dis, 2003, 35:15-20
  • 9[4]Jokinen C, Heiskanen L, Juvonen H,et al.Microbial etiology of community-acquired pneumonia in the adult population of 4 municipalities in eastern Finland[J]. Clin Infect Dis, 2001, 32:1141-1154
  • 10[5]Principi N, Esposito , Blasi F,et al.Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired lower respiratory tract infections[J]. Clin Infect Dis, 2001, 32:1281-1289

共引文献1857

同被引文献25

  • 1康维明,赵玉沛.氟喹诺酮类抗菌药在外科系统感染预防及治疗中的合理应用[J].中国社区医师,2006,22(8):23-24. 被引量:4
  • 2社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655. 被引量:3032
  • 3中华人民共和国卫生部.关于抗菌药物临床应用管理有关问题的通知[S] ,卫办医政发(2009)38号,2009.
  • 4Mandell LA,Wunderink RG,Anzueto A,et al.Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults[J].Clin Infect Dis,2007,44(S2):S27-S72.
  • 5Schuetz P,Christ-Crain M,Thomann R,et al.Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections:The ProHOSP Randomized Controlled Trial[J].JAMA,2009,302(10):1059-66.
  • 6Chalmers JD,Singanayagam A,Akram AR,et al.Severity assessment tools for predicting mortality in hospitalised patients with community-acquired pneumonia.Systematic review and meta-analysis[J].Thorax,2010,65(10):878-83.
  • 7Schuetz P,Christ-Crain M,Mueller B.Procalcitonin and other biomarkers to improve assessment and antibiotic stewardship in infections-hope for hype[J] ? Swiss Med Wkly,2009,139(23-24):318-26.
  • 8Krüger S,Ewig S,Marre R,et al.Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes[J].Eur Respir J,2008(2):349-55.
  • 9Boussekey N,Leroy O,Alfandari S,et al.Procalcitonin kinetics in the prognosis of severe community-acquired pneumonia[J].Intensive Care Med,2006,32(3):469-72.
  • 10Bafadhel M,Clark TW.Procalcitonin and C reactive protein in hospitalised adult patients with community acquired pneumonia,exacerbation of asthma and chronic obstructive pulmonary disease[J].Chest;Prepublished online October 28,2010.DOI 10.1378/chest.10-1747.

引证文献4

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部